114 related articles for article (PubMed ID: 6362630)
1. Activation of the alternate complement pathway by peptidoglycan of Actinomyces viscosus, a potentially pathogenic oral bacterium.
Baker JJ; Billy SA
Arch Oral Biol; 1983; 28(11):1073-5. PubMed ID: 6362630
[TBL] [Abstract][Full Text] [Related]
2. Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides--studies on active components and structural requirements.
Kawasaki A; Takada H; Kotani S; Inai S; Nagaki K; Matsumoto M; Yokogawa K; Kawata S; Kusumoto S; Shiba T
Microbiol Immunol; 1987; 31(6):551-69. PubMed ID: 3670125
[TBL] [Abstract][Full Text] [Related]
3. Peptidoglycan from the potentially pathogenic oral bacterium Actinomyces viscosus is a B-cell mitogen.
Baker JJ
Arch Oral Biol; 1985; 30(3):291-4. PubMed ID: 3873234
[TBL] [Abstract][Full Text] [Related]
4. Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.
Spitznagel JK; Goodrum KJ; Warejcka DJ; Weaver JL; Miller HL; Babcock L
Infect Immun; 1986 Jun; 52(3):803-11. PubMed ID: 3086232
[TBL] [Abstract][Full Text] [Related]
5. [The manifestation of functional heterogeneity of the peptidoglycans in opsonophagocytic reactions].
Maianskiĭ AN; Sibiriakova NI; Astaf'ev DG; Fokina IuV
Zh Mikrobiol Epidemiol Immunobiol; 1993; (2):114-8. PubMed ID: 8059563
[TBL] [Abstract][Full Text] [Related]
6. The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.
Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Verhoef J
Immunology; 1979 Jul; 37(3):615-21. PubMed ID: 500119
[TBL] [Abstract][Full Text] [Related]
7. Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies.
Verbrugh HA; van Dijk WC; Peters R; van Erne ME; Daha MR; Peterson PK; Verhoef J
J Immunol; 1980 Mar; 124(3):1167-73. PubMed ID: 7358981
[No Abstract] [Full Text] [Related]
8. Factors affecting complement activation by Staphylococcus aureus cell walls, their components, and mutants altered in teichoic acid.
Wilkinson BJ; Kim Y; Peterson PK
Infect Immun; 1981 Apr; 32(1):216-24. PubMed ID: 7216486
[TBL] [Abstract][Full Text] [Related]
9. The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Douglas SD; Quie PG; Verhoef J
J Clin Invest; 1978 Mar; 61(3):597-609. PubMed ID: 641141
[TBL] [Abstract][Full Text] [Related]
10. Activation of complement by cell surface components of Staphylococcus aureus.
Wilkinson BJ; Kim Y; Peterson PK; Quie PG; Michael AF
Infect Immun; 1978 May; 20(2):388-92. PubMed ID: 669803
[TBL] [Abstract][Full Text] [Related]
11. Biological characteristics of peptidoglycans of group A streptococcus and some other bacterial species. II. Immunological mechanisms involved in thrombocytolysis.
Rýc M; Rotta J
J Hyg Epidemiol Microbiol Immunol; 1978; 22(4):435-41. PubMed ID: 38280
[TBL] [Abstract][Full Text] [Related]
12. Polyclonal response of human lymphocytes to bacterial cell walls, peptidoglycans and teichoic acids.
Räsänen L; Mustikkamäki UP; Arvilommi H
Immunology; 1982 Jul; 46(3):481-6. PubMed ID: 6807836
[TBL] [Abstract][Full Text] [Related]
13. Chemical and antigenic properties of the cell wall of Actinomyces viscosus (Strain T6).
Reed MJ
J Dent Res; 1972; 51(5):1193-202. PubMed ID: 4506556
[No Abstract] [Full Text] [Related]
14. Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall.
Greenblatt J; Boackle RJ; Schwab JH
Infect Immun; 1978 Jan; 19(1):296-303. PubMed ID: 415005
[TBL] [Abstract][Full Text] [Related]
15. Biological characteristics of peptidoglycans of group A streptococcus and some other bacterial species. I. Tolerance and effect of antibody in fever response, and heart damaging effect in rabbits.
Rotta J; Bednár B; Rýc M
J Hyg Epidemiol Microbiol Immunol; 1977; 21(4):433-40. PubMed ID: 25304
[TBL] [Abstract][Full Text] [Related]
16. Novel antigens of oral Actinomyces species prepared from a cell wall enzyme lysate.
Hamada S; Okahashi N; Kimura S; Imanishi H; Koga T; Kawata S; Michalek SM; McGhee JR
Jpn J Med Sci Biol; 1982 Aug; 35(4):171-81. PubMed ID: 7154407
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of reticuloendothelial system and toxicity to macrophages of Staphylococcus aureus cell wall, peptidoglycan, and teichoic acid.
Dziarski R
Zentralbl Bakteriol Orig A; 1977 Jul; 238(3):320-9. PubMed ID: 910577
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus peptidoglycan studied by electron microscopy of immunoperoxidase-treated sections of cell walls.
Solsvik E; Grov A; Endresen C
Acta Pathol Microbiol Immunol Scand B; 1984 Feb; 92(1):7-12. PubMed ID: 6201037
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil chemotactic activity of peptidoglycan. A comparison between Staphylococcus aureus and Staphylococcus epidermidis.
Riber U; Espersen F; Wilkinson BJ; Kharazmi A
APMIS; 1990 Oct; 98(10):881-6. PubMed ID: 2245008
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immune reactions in vitro to cell walls and peptidoglycan from Staphylococcus aureus.
Targowski SP; Berman DT
Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):295-301. PubMed ID: 126563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
